![](https://investorshub.advfn.com/uicon/451367.png?cb=1598043651)
Friday, June 02, 2023 1:29:01 PM
HINGHAM, Mass., June 02, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 701,756 shares of the Company’s common stock at a purchase price of $2.1375 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered series C preferred investment options. The series C preferred investment options to purchase up to 350,878 shares of common stock have an exercise price of $2.075 per share and are immediately exercisable for a period of five and one-half years following issuance. The closing of the registered direct offering and the concurrent private placement is expected to occur on or about June 6, 2023, subject to the satisfaction of customary closing conditions.
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offerings.
Recent MBOT News
- Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial • GlobeNewswire Inc. • 06/20/2024 12:25:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 12:30:20 PM
- Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial • GlobeNewswire Inc. • 06/17/2024 12:30:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 06/11/2024 05:15:27 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/11/2024 05:14:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 08:35:13 PM
- Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules • GlobeNewswire Inc. • 06/04/2024 08:20:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/04/2024 12:30:21 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 06/03/2024 08:01:46 PM
- Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules • GlobeNewswire Inc. • 06/03/2024 04:11:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 12:20:23 PM
- Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial • GlobeNewswire Inc. • 06/03/2024 12:20:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/16/2024 08:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 12:45:44 PM
- Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™ • GlobeNewswire Inc. • 04/29/2024 12:30:00 PM
- Microbot Medical Shares Status Following Recent Geopolitical Events • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 11:41:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 11:41:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 11:41:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 11:41:08 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/20/2024 09:35:10 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:49:35 PM
- Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US • GlobeNewswire Inc. • 02/05/2024 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/30/2024 09:30:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 12:20:27 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM